MedTrace Logo

Prevalence and Risk Factors Nocturnal Polyuria in Female OAB

NCT03810027 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1071

Last updated 2019-01-18

No results posted yet for this study

Summary

Nocturnal polyuria may decrease the treatment efficacy of overactive bladder syndrome (OAB); and adjuvant medication, such as desmopressin, may be needed for the treatment of nocturnal polyuria. The knowledge of prevalence and risk factors of nocturnal polyuria might be important for the treatment of OAB. Thus, our aim is to describe the prevalence and risk factors of nocturnal polyuria in women with OAB.

Conditions

  • Nocturia

Interventions

DIAGNOSTIC_TEST

Bladder diary

3-day bladder diary

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Ho-Hsiung Lin, PhD · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-01
Primary Completion
2018-01-31
Completion
2018-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03810027 on ClinicalTrials.gov